EI
BIO icon

Ethic Inc’s Bio-Rad Laboratories Class A BIO Stock Holding History

Ethic Inc’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,339
Closed -$373K – 1370
2026
Q1 		$373K Sell
1,339
-580
-30% -$167K 0.01% 976
2025
Q4 		$581K Buy
1,919
+1,193
+164% +$372K 0.01% 803
2025
Q3 		$204K Sell
726
-1,843
-72% -$502K ﹤0.01% 1119
2025
Q2 		$627K Sell
2,569
-1,096
-30% -$259K 0.01% 743
2025
Q1 		$880K Buy
3,665
+2,067
+129% +$622K 0.02% 624
2024
Q4 		$525K Buy
1,598
+522
+49% +$177K 0.01% 792
2024
Q3 		$372K Buy
1,076
+132
+14% +$41.9K 0.01% 836
2024
Q2 		$258K Sell
944
-132
-12% -$38.4K 0.01% 957
2024
Q1 		$372K Sell
1,076
-372
-26% -$122K 0.01% 834
2023
Q4 		$468K Buy
1,448
+403
+39% +$126K 0.01% 755
2023
Q3 		$375K Sell
1,045
-419
-29% -$162K 0.01% 755
2023
Q2 		$555K Sell
1,464
-349
-19% -$142K 0.02% 618
2023
Q1 		$868K Sell
1,813
-276
-13% -$129K 0.04% 480
2022
Q4 		$878K Buy
2,089
+146
+8% +$58.9K 0.05% 409
2022
Q3 		$811K Buy
1,943
+766
+65% +$382K 0.06% 375
2022
Q2 		$583K Buy
+1,177
New +$613K 0.04% 436

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Ethic Inc's BIO Position: Q2 2026 in Review

Ethic Inc sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2026, closing a stake of 1,339 shares — an estimated $373K sold.

Ethic Inc first reported a position in BIO in Q2 2022 and held it in 16 quarters. The position peaked at $880K in Q1 2025. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Ethic Inc reported no remaining Bio-Rad Laboratories Class A position as of Q2 2026 after selling out during the quarter.
  • Ethic Inc sold 1,339 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $373K.
  • Ethic Inc first reported a position in Bio-Rad Laboratories Class A in Q2 2022 and held it in 16 quarters.
  • Ethic Inc's Bio-Rad Laboratories Class A position peaked at $880K in Q1 2025.
  • 398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.